The Impact of the Covid-19 Pandemic on New and Ongoing Clinical Trials
Navigating the COVID-19 Pandemic, Preparing for the Rest of 2020 & Planning a Return to "Normalcy" in the New Clinical Trial Landscape 

June 25 - 26, 2020 | Digital Event

The first half of 2020 has significantly impacted the clinical trial landscape. As clinical trial hosts, sites and management leaders continue to navigate the impact of the ongoing pandemic, convene in a virtually interactive environment with other life science leaders to:

  • Gain FDA guidance in real-time for new and ongoing trials, and take part in an interactive Q&A to discuss due diligence, compliance and preparation for what comes next
  • Identify opportunities for enhanced patient engagement presented by the post-Covid19 trial environment
  • Hear best practices from pioneers in telehealth and how to avoid the pitfalls when integrating it into your future trial design 
  • Understand the risk and what needs to be in place before diving into remote, digital trial models and e health solutions
  • Take part in an interactive virtual experience and convene with key decision makers in clinical trial design, strategy and operations as they discuss challenges facing the industry and how to overcome them

Featured Speakers